Fluvastatin-D8 (Major) Sodium Salt

• Catalog No.: F601252
• CAS Number: 1260178-87-7
• M. F.: C24H25FNNaO4
• M. W.: 433.4477732
• Storage: -20°C Freezer, Under Inert Atmosphere

SYNONYMS

• IUPAC name: sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-[(^2H₇)propan-2-yl](5,7-^2H₂)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
• IUPAC Traditional name: sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-[(^2H₇)propan-2-yl](5,7-^2H₂)indol-2-yl]-3,5-dihydroxyhept-6-enoate
• Synonyms: Lescol-D8; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl-deuterated)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt; Lipaxan-D8; Fluindostatin-D8; XU 62-320-D8; Primexin-D8

DATABASE IDS

• CAS Number: 1260178-87-7

PROPERTIES

• Apperance: Yellow to Light Orange Solid
• Melting Point: 194-197°C
• Solubility: Methanol
• Solubility: Water
• Storage Condition: -20°C Freezer, Under Inert Atmosphere

DETAILS

Description (English)

A synthetic HMG-CoA reductase inhibitor. Antilipemic.A representative lot was: 1% of d6, 28% of d7, 37% of d8, 21% of d9, 10% of d10, and 2% of d11

REFERENCES

• Yuan, J., et al.: Atherosclerosis, 87, 147 (1991)
• Tse, F.L.S., et al.: J. Clin. Pharmacol., 32, 630 (1991)
• Dain, J.G., et al.: Drug Metab. Disposit., 21, 567 (1991)